Cite
HARVARD Citation
Maslah, N. et al. (2021). In vitro assessment of the sensitivity to APR‐246 + azacitidine combination predicts response to this combination in myelodysplastic/acute myeloid leukaemia patients. British journal of haematology. pp. e77-e79. [Online].